IndraLab

Statements

USP8 binds ESR1. 1 / 1

| 1

sparser

"Overall, our findings suggest that DC-U4106 is a promising drug candidate and targeting the USP8-ERα complex could be a new approach to treat ER-positive or drug-resistant breast cancer."

35786929

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP8 binds ESR1. 1 / 1

INDRA sources:

Databases

Reading